Regeneron Pharmaceuticals (NasdaqGS:REGN) Q2 2026 Earnings call July 30, 2026 08:30 AM ET Company Participants Ryan Crowe - SVP of Investor Relations and Strategic Analysis Leonard Schleifer - Co-Founder, Board Co-Chair, President, and CEO George Yancopoulos - Co-Founder, Board Co-Chair, President, and Chief Scientific Officer Marion McCourt - EVP of Commercial Chris Fenimore - EVP of Finance and CFO Conference Call Participants Chris Raymond - Analyst Taylor Henley - Analyst Tyler Van Buren - Analyst Cory ...